Report cover image

Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033

Publisher BIS Research
Published Sep 24, 2024
SKU # BIS19153787

Description

Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033

Introduction to Asia-Pacific (APAC) Continuous Bioprocessing Market

The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033. Increased demand to improve biopharmaceutical production through increased yield, flexibility, productivity, and product consistency at the same time as lower manufacturing costs is driving the APAC market for continuous bioprocessing. In order to produce consistent results, bioprocessing has been moving toward continuous mode in recent years. The goal of ongoing efforts is to integrate downstream bioprocessing into a continuous operation, thereby increasing the efficiency and capabilities of the industry, even though continuous upstream bioprocessing has been established and widely adopted.

Market Introduction

The Asia-Pacific continuous bioprocessing market is expanding quickly as the area assumes a pivotal role in the worldwide biopharmaceutical sector. As the emphasis on improving productivity, adaptability, and product quality grows, continuous bioprocessing is becoming recognized as a game-changing strategy for biomanufacturing in the Asia-Pacific region. Many benefits, such as increased yields, lower manufacturing costs, and the capacity to produce reliable, high-quality products, make this strategy a desirable one for biopharmaceutical companies operating in the area.

The region's strong biopharmaceutical manufacturing infrastructure and the rising demand for novel therapies have led to the widespread adoption of continuous upstream bioprocessing in APAC. The emphasis now is on integrating continuous downstream bioprocessing, optimizing overall process efficiency, and further streamlining operations. With seamless production flows from beginning to end, decreased downtime, and improved scalability of biopharmaceutical production, this integration is predicted to be a game-changer.

The continuous development of bioprocessing technologies is being fueled by the region's substantial investment in research and development as well as encouraging government initiatives. Continuous bioprocessing adoption is expected to pick up speed as the APAC biopharmaceutical market grows, establishing the region as a pioneer in cutting-edge biomanufacturing techniques.

Market Segmentation

Segmentation 1: by Product

Chromatography Systems and Consumables
Filtration Systems and Devices
Bioreactors
Cell Culture Media, Cell Lines, Buffers, and Reagents
Other Products

Segmentation 2: by Application

Monoclonal Antibodies
Vaccines
Cell and Gene Therapy
Other Applications

Segmentation 3: by End User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Contract Research Organizations

Segmentation 4: by Country

Japan
India
China
South Korea
Australia
Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific continuous bioprocessing market has been segmented based on application, end user, and product. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: In the continuous bioprocessing market, competitive strategy centers around innovation, collaboration, customization, and sustainability. Companies in the market strive to innovate by developing more efficient, scalable, and flexible bioprocessing technologies that reduce production times and costs while maintaining high product quality. Collaboration between equipment manufacturers, biopharmaceutical companies, and research institutions is crucial for sharing knowledge, optimizing processes, and accelerating the adoption of continuous bioprocessing.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 1-5 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Continuous Bioprocessing Market Trend Analysis
1.1.2 Digitization of Continuous Bioprocessing by the Biopharmaceutical Industry
1.1.3 Increasing Use of Single-Use or Disposable Bioprocessing Equipment
1.2 Supply Chain Overview
1.2.1 Value Chain Analysis
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, by Year)
1.4 Regulatory Landscape
1.5 Impact Analysis for Key Events: COVID-19
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.1.1 Growing Demand for Continuous Bioprocessing due to the Flourishing Biopharmaceutical Sector
1.6.1.2 Cost Reduction with Continuous Bioprocessing as Compared to Batch and Fed-Batch Bioprocessing
1.6.1.3 Increasing Adoption of New Technologies like Single-Use Bioprocessing Technology
1.6.2 Market Restraints
1.6.2.1 Technological Complexities and Operational Challenges
1.6.2.2 High Initial Cost Associated with Continuous Bioprocessing
1.6.3 Market Opportunities
1.6.3.1 Numerous Proposed Technologies in Continuous Bioprocessing
1.6.3.2 Moving Closer to End-to-End Continuous Bioprocessing
2 Region
2.1 Regional Summary
2.2 Asia-Pacific
2.2.1 Regional Overview
2.2.2 Driving Factors for Market Growth
2.2.3 Factors Challenging the Market
2.2.4 Application
2.2.5 Product
2.2.6 China
2.2.7 Application
2.2.8 Product
2.2.9 India
2.2.10 Application
2.2.11 Product
2.2.12 Australia
2.2.13 Application
2.2.14 Product
2.2.15 Japan
2.2.16 Application
2.2.17 Product
2.2.18 South Korea
2.2.19 Application
2.2.20 Product
2.2.21 Rest-of-Asia-Pacific
2.2.22 Application
2.2.23 Product
3 Markets - Competitive Benchmarking & Company Profiles
3.1 Next Frontiers
3.2 Geographic Assessment
3.2.1 OmniBRx Biotechnologies Pvt Ltd.
3.2.1.1 Overview
3.2.1.2 Top Products/Product Portfolio
3.2.1.3 Top Competitors
3.2.1.4 Target Customers
3.2.1.5 Key Personnel
3.2.1.6 Analyst View
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast
List of Figures
Figure 1: Asia-Pacific Continuous Bioprocessing Market, $Million, 2023, 2026, and 2033
Figure 2: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022, 2026, and 2033
Figure 3: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022, 2026, and 2033
Figure 4: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022, 2026, and 2033
Figure 5: Evolution of Single-Use Facilities, 2019-2022
Figure 6: Supply Chain and Identifying Risks within the Supply Chain
Figure 7: Continuous Bioprocessing Market (by Country), January 2020-December 2023
Figure 8: Continuous Bioprocessing Market (by Year), January 2020-December 2023
Figure 9: Long-Term Effect of COVID-19 on Bioprocessing, Biopharma Vs Suppliers
Figure 10: Impact of COVID-19 on the Continuous Bioprocessing Market, Pre, During, and Post-COVID-19 Scenario
Figure 11: Impact Analysis of Market Navigating Factors, 2023-2033
Figure 12: Growth of Biopharmaceutical Research and Development, 2012-2022, $ Million
Figure 13: Comparison of Processes and Facilities for Different Batch Types
Figure 14: Cost Comparison: Continuous vs. Batch and Fed-Batch Bioprocessing, $ Million
Figure 15: Respondents Using Single-Use Bioprocessing Technology, All Scales (R&D to Commercial), 2018-2022, %
Figure 16: Novel Bioprocessing Systems/Innovations Evaluated in 12 Months, 2021
Figure 17: Factors Contributing to High Initial Costs in Continuous Bioprocessing Facilities
Figure 18: Proposed Technologies in Continuous Biopharmaceutical Manufacturing
Figure 19: Developments in Continuous Bioprocessing Generating Need for End-to-End Continuous Bioprocessing Facilities
Figure 20: China Continuous Bioprocessing Market, $Million, 2022-2033
Figure 21: India Continuous Bioprocessing Market, $Million, 2022-2033
Figure 22: Australia Continuous Bioprocessing Market, $Million, 2022-2033
Figure 23: Japan Continuous Bioprocessing Market, $Million, 2022-2033
Figure 24: South Korea Continuous Bioprocessing Market, $Million, 2022-2033
Figure 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market, $Million, 2022-2033
Figure 26: Strategic Initiatives, 2020-2023
Figure 27: Share of Strategic Initiatives, 2020-2023
Figure 28: Data Triangulation
Figure 29: Top-Down and Bottom-Up Approach
Figure 30: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Continuous Bioprocessing Market, Opportunities
Table 3: Product Portfolio Company Positioning
Table 4: Example of Digitization of Continuous Bioprocessing
Table 5: Survey on Industry Perceptions of Continuous Bioprocessing Vs Batch-Fed Processing (N=140+ Biopharmaceutical Companies)
Table 6: Continuous Bioprocessing Market (by Region), $Million, 2022-2033
Table 7: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 8: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 9: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 10: China Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 11: China Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 12: China Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 13: India Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 14: India Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 15: India Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 16: Australia Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 17: Australia Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 18: Australia Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 19: Japan Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 20: Japan Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 21: Japan Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 22: South Korea Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 23: South Korea Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 24: South Korea Continuous Bioprocessing Market (by Product), $Million, 2022-2033
Table 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
Table 26: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
Table 27: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us